Effects of BRCA1 and BRCA2 mutations on female fertility

Proceedings of the Royal Society B: Biological Sciences

Volumn 279, Issue 1732, 2012, Pages 1389-1395

  Smith, Ken R ^a,b   Hanson, Heidi A ^b   Mineau, Geraldine P ^b,c   Buys, Saundra S ^b,c  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; BRCA2; Fertility; Mortality; Pleiotropy; Telomeres

Indexed keywords

CANCER; FERTILITY; FITNESS; MORALITY; MUTATION; PLEIOTROPY;

EID: 84863393398     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.2011.1697     Document Type: Article

References (34)

1. Botkin, J.R., Croyle, R.T., Smith, K.R., Baty, B. J., Lerman, C., Goldgar, D. E., Ward, J. M., Flick, B. J. & Nash, J. E. 1996 Amodelprotocol for evaluatingthebehavioral andpsychosocial effects of BRCA1 testing. J. Natl Cancer Inst. 88, 872-882. (doi:10.1093/jnci/88.13.872)
2. Easton, D. F., Ford, D. & Bishop, D. T. 1995 Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 56, 265-271.
3. Friedman, E. et al. 2006 Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res. 8, R15. (doi:10.1186/bcr1387)
4. Moslehi, R., Singh, R., Lessner, L. & Friedman, J. M. 2010 Impact of BRCA mutations on female fertility and offspring sex ratio. Am. J. Hum. Biol. 22, 201-205.
5. Mai, P. L., Chatterjee, N., Hartge, P., Tucker, M., Brody, L., Struewing, J. P., Wacholder, S. & Toland, A. E. 2009 Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma. PLoS ONE 4, e4812. (doi:10.1371/journal.pone.0004812)
6. Williams, G. C. 1957 Pleiotropy, natural selection, and the evolution of senescence. Evolution 11, 398-411. (doi:10.2307/2406060)
7. Pavard, S. & Metcalf, C. J. 2007 Negative selection on BRCA1 susceptibility alleles sheds light on the population genetics of late-onset diseases and aging theory. PLoSONE 2, e1206. (doi:10.1371/journal.pone.0001206)
8. Frost, C., Venne, V., Cunningham, D. & Gerritsen-McKane, R. 2004 Decision making with uncertain information: learning from women in a high risk breast cancer clinic. J. Genet. Couns. 13, 221. (doi:10.1023/B:JOGC.0000027958.02383.a9)
9. John, E. M. et al. 2004 The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res. 6, R375-R389. (doi:10.1186/bcr801)
10. Frank, T. S. et al. 2002 Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J. Clin. Oncol. 20, 1480-1490. (doi:10.1200/JCO.20.6.1480)
11. Bean, L., Mineau, G. & Anderton, D. 1990 Fertility change on the American frontier: adaptation and innovation. Berkeley, CA: University of California Press.
12. Wylie, J. E. & Mineau, G. P. 2003 Biomedical databases: protecting privacy and promoting research. Trends Biotechnol. 21, 113-116. (doi:10.1016/S0167-7799(02) 00039-2)
13. Ferla, R. et al. 2007 Founder mutations in BRCA1 and BRCA2 genes. Ann. Oncol. 18(Suppl. 6), vi93-vi98. (doi:10.1093/annonc/mdm234)
14. Neuhausen, S. L. et al. 1996 Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am. J. Hum. Genet. 58, 271-280.
15. Giscard d'Estaing, S., Perrin, D., Lenoir, G. M., Guerin, J. F. & Dante, R. 2005 Upregulation of the BRCA1 gene in human germ cells and in preimplantation embryos. Fertil. Steril. 84, 785-788. (doi:10.1016/j.fertnstert.2005.02.037)
16. Liu, C. Y., Flesken-Nikitin, A., Li, S., Zeng, Y.& Lee, W.H. 1996 Inactivation of themouse BRCA1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10, 1835-1843. (doi:10.1101/gad.10.14.1835)
17. Scully, R. & Livingston, D. M. 2000 In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429-432. (doi:10.1038/35044000)
18. de la Hoya, M., Fernandez, J. M., Tosar, A., Godino, J., Sanchez de Abajo, A., Vidart, J. A., Pérez-Segura, P. & Díaz-Rubio, E. 2003 Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or both. JAMA 290, 929-931. (doi:10.1001/jama.290.7.929)
19. Pal, T., Keefe, D., Sun, P. & Narod, S. A. 2010 Fertility in women with BRCA mutations: a case-control study. Fertil. Steril. 93, 1805-1808. (doi:10.1016/j.fertnstert.2008.12.052)
20. French, J. D., Dunn, J., Smart, C. E., Manning, N. & Brown, M. A. 2006 Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines. Genes Chromosomes Cancer 45, 277-289. (doi:10.1002/gcc.20290)
21. Xiong, J. et al. 2003 BRCA1 inhibition of telomerase activity in cultured cells. Mol. Cell Biol. 23, 8668-8690. (doi:10.1128/MCB.23.23.8668-8690.2003)
22. Ballal, R. D., Saha, T., Fan, S., Haddad, B. R. & Rosen, E. M. 2009 BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage. J. Biol. Chem. 284, 36 083-36 098. (doi:10.1074/jbc.M109.025825)
23. McPherson, J. P. et al. 2006 A role for Brca1 in chromosome end maintenance. Hum. Mol. Genet. 15, 831-838. (doi:10.1093/hmg/ddl002)
24. Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A. & Kerber, R. A. 2003 Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361, 393-395. (doi:10.1016/S0140-6736(03)12384-7)
25. Keefe, D. L., Franco, S., Liu, L., Trimarchi, J., Cao, B., Weitzen, S., Agarwal, S. & Blasco, M. A. 2005 Telomere length predicts embryo fragmentation after in vitro fertilization in women: toward a telomere theory of reproductive aging in women. Am. J. Obstet. Gynecol. 192, 1256-1260. (doi:10.1016/j.ajog.2005.01.036)
26. Keefe, D. L., Marquard, K. & Liu, L. 2006 The telomere theory of reproductive senescence in women. Curr. Opin. Obstet. Gynecol. 18, 280-285. (doi:10.1097/01.gco.0000193019.05686.49)
27. Aydos, S. E., Elhan, A. H. & Tukun, A. 2005 Is telomere length one of the determinants of reproductive life span? Arch. Gynecol. Obstet. 272, 113-116. (doi:10.1007/s00404-004-0690-2)
28. Hanna, C. W., Bretherick, K. L., Gair, J. L., Fluker, M. R., Stephenson, M. D. & Robinson, W. P. 2009 Telomere length and reproductive aging. Hum. Reprod. 24, 1206-1211. (doi:10.1093/humrep/dep007)
29. Tryggvadottir, L., Olafsdottir, E., Gudlaugsdottir, S., Thorlacius, S., Jonasson, J., Tulinius, H. & Eyfjord, J. E. 2003 BRCA2 mutation carriers, reproductive factors and breast cancer risk. Breast Cancer Res. 5, R121-R128. (doi:10.1186/bcr619)
30. Jernstrom, H. et al. 1999 Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet 354, 1846-1850. (doi:10.1016/S0140-6736(99) 04336-6)
31. Smith, K. R., Ellington, L., Chan, A. Y., Croyle, R. T. & Botkin, J. R. 2004 Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiol. Biomarkers Prev. 13, 733-740.
32. Botkin, J. R. et al. 2003 Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am. J. Med. Genet. A 118, 201-209. (doi:10.1002/ajmg.a.10102)
33. Narod, S. A. 2001 Hormonal prevention of hereditary breast cancer. Ann. NY Acad. Sci. 952, 36-43. (doi:10.1111/j.1749-6632.2001.tb02726.x)
34. Cullinane, C. A. 2005 Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int. J. Cancer 117, 988-991. (doi:10.1002/ijc.21273)